NMRA-335140

· Neumora Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for NMRA-335140, covering 2025-11-26 to 2026-07-06. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder [Phase 3]

See pricing